KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Debt Ratio: 2011-2025

Historic Debt Ratio for Supernus Pharmaceuticals (SUPN) over the last 6 years, with Sep 2025 value amounting to 0.01.

  • Supernus Pharmaceuticals' Debt Ratio fell 77.19% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10, marking a year-over-year decrease of 35.23%. This contributed to the annual value of 0.03 for FY2024, which is 15.09% down from last year.
  • As of Q3 2025, Supernus Pharmaceuticals' Debt Ratio stood at 0.01, which was down 64.46% from 0.02 recorded in Q1 2025.
  • Over the past 5 years, Supernus Pharmaceuticals' Debt Ratio peaked at 0.25 during Q4 2021, and registered a low of 0.01 during Q3 2025.
  • Its 3-year average for Debt Ratio is 0.03, with a median of 0.04 in 2023.
  • Examining YoY changes over the last 5 years, Supernus Pharmaceuticals' Debt Ratio showed a top increase of 1,480.60% in 2022 and a maximum decrease of 95.06% in 2022.
  • Over the past 5 years, Supernus Pharmaceuticals' Debt Ratio (Quarterly) stood at 0.25 in 2021, then tumbled by 95.06% to 0.01 in 2022, then soared by 228.52% to 0.04 in 2023, then decreased by 15.09% to 0.03 in 2024, then crashed by 77.19% to 0.01 in 2025.
  • Its Debt Ratio stands at 0.01 for Q3 2025, versus 0.02 for Q1 2025 and 0.03 for Q4 2024.